Loading clinical trials...
Loading clinical trials...
Alcoholic liver disease is characterized by circulating T cell activation and liver T cell infiltration but their phenotype is poorly studied. The aim of the study is to test the hypothesis that the (...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Erasme University Hospital
NCT03209791 · Alcoholic Liver Disease
NCT05895890 · Alcoholic Liver Disease
NCT03267069 · Alcoholic Liver Disease
NCT05007470 · Alcohol Use Disorder, Alcoholic Liver Disease, and more
NCT06907563 · Steatotic Liver Disease, MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis), and more
Hopital Erasme - Dpt of Gastroenterology
Brussels
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions